Navigation Links
Will Rogers Institute Awards Top Doctor $50,000 for Outstanding Contributions to Lung Research
Date:2/9/2011

BURBANK, Calif., Feb. 9, 2011 /PRNewswire/ -- The Will Rogers Institute's annual prize for outstanding contributions to lung research has been awarded to Dr. Anthony Fauci. The $50,000 award was created to honor individuals for extraordinary work leading to advancements in treatment for lung diseases. He is the fourth recipient of the prestigious prize from the Will Rogers Institute.

(Photo:  http://photos.prnewswire.com/prnh/20110209/LA45608)

Dr. Fauci has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated diseases. He has developed effective therapies for formerly fatal inflammatory and immune-mediated diseases such as polyarteritis nodosa, Wegener's granulomatosis, and lymphomatoid granulomatosis. Dr. Fauci has made influential contributions to the understanding of how HIV destroys the body's defenses leading to the progression of AIDS, and he has played an important role in developing strategies for the therapy and immune reconstitution of patients with this disease, as well as for a vaccine to prevent HIV infection.

In 1984, Dr. Fauci became Director of NIAID (National Institutes of Allergy and Infectious Diseases), where he oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma, and allergies.

Ted Cooper, president of the Will Rogers Institute, stated "Dr. Fauci was honored by the Institute because his work has consistently produced outstanding and influential research and he has been on the front lines of the HIV epidemic since day one."

The Will Rogers Institute is a program of the Will Rogers Motion Picture Pioneers Foundation, a charity named after one of the greatest humanitarians, philanthropists, and entertainers, Will Rogers. Will Rogers Institute is a national charitable health program focused on research of debilitating lung disorders, medical school training fellowships and distribution of free health education materials to the general public. The Institute recently became a national leader in providing life saving neonatal ventilator equipment to hospitals across the country.  For more information, visit www.wrinstitute.org.Contact:Todd Vradenburg Will Rogers Motion Picture Pioneers Foundation (818) 755-2324
'/>"/>

SOURCE Will Rogers Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
3. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
4. Cyntellect to Collaborate With the Burnham Institute for Medical Research
5. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
6. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
9. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
10. Annual List of Best Doctors in Dallas Showcases Texas Institute for Surgery Physicians
11. LifeModeler, Inc. Provides $400,000 Grant to InMotion Musculoskeletal Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):